Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.

Mol Med · 2024 · PMC11055298 · PMID 38671369

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

For the first time, we confirmed how G-Rh2 changed the biometabolic behavior of tumors by regulating PDK4, leading to a favorable trend towards normal apoptotic programming.

also in 559 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.